Boston Scientific hits all endpoints in CRM trial
Boston Scientific has announced six-month positive results from its ongoing pivotal MODULAR ATP clinical trial examining the company’s modular cardiac rhythm management (mCRM) technology. The findings published in the New England Journal of Medicine detail …